Cigna Rolls Out New Plan to Fully Cover Multi-Million Dollar Gene Therapies

Source: Reuters

Health insurer Cigna Corp has introduced a plan to fully cover costs for expensive gene therapies, eliminating any out-of-pocket payments for customers, according to a Reuters report.

Gene therapies, which in general aim to treat diseases by manipulating genes at a cellular level, are among the most expensive treatments in the world.

While there are only two approved gene therapies in the United States, drugmakers have been pouring in millions of dollars into the development of these treatments that could offer a potential one-time cure to rare and life-threatening disorders.

Read the full article.

Recent Content